Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 023738/0001 | |
| Pages: | 112 |
| | Recorded: | 01/06/2010 | | |
Attorney Dkt #: | 303989/83598/81602/82271 |
Conveyance: | MERGER (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
3
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11885061
|
Filing Dt:
|
08/28/2008
|
Publication #:
|
|
Pub Dt:
|
01/15/2009
| | | | |
Title:
|
Drug Forms Having Controlled Bioavailability
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11988991
|
Filing Dt:
|
02/27/2009
|
Publication #:
|
|
Pub Dt:
|
08/27/2009
| | | | |
Title:
|
Use of soluble guanylate cyclase activators for the treatment of Raynaud's Phenomenon
|
|
|
Patent #:
|
|
Issue Dt:
|
05/01/2012
|
Application #:
|
12083761
|
Filing Dt:
|
05/19/2009
|
Publication #:
|
|
Pub Dt:
|
11/19/2009
| | | | |
Title:
|
CYCLOPROPYLACETIC ACID DERIVATIVES AND USE THEREOF
|
|
Assignee
|
|
|
MULLERSTR. 178 |
BERLIN, GERMANY 13353 |
|
Correspondence name and address
|
|
EDWARDS ANGELL PALMER & DODGE LLP
|
|
P.O. BOX 55874
|
|
BOSTON, MA 02205
|
Search Results as of:
09/23/2024 01:26 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|